Improving Medication Adherence Through a Health Literacy-based Intervention for Coronary Heart Disease Patients With Low Health Literacy
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Coronary Disease
- Sponsor
- Chinese University of Hong Kong
- Enrollment
- 60
- Locations
- 2
- Primary Endpoint
- Change from baseline medication adherence at 4-weeks follow-up
- Last Updated
- 6 years ago
Overview
Brief Summary
This is a multi-center pilot study to examine the effectiveness of a health literacy-based intervention to improve medication adherence and self-efficacy of medication use among individuals with coronary heart disease (CHD). The specific aims are to: i) develop a health literacy-based intervention to improve medication adherence for CHD individuals with low health literacy and ii) evaluate the effects of a health literacy-based intervention on improving medication adherence and self-efficacy in CHD individuals.
Detailed Description
The project will be conducted in 2 phases. Phase 1 is to develop the health literacy-based intervention that consists of a video and an education booklet. Phase 2 is to conduct a pilot study to evaluate the effectiveness of the intervention. A total of 60 participants with low health literacy and diagnosed with CHD will be recruited in two settings. Data will be collected at baseline and 4-weeks after enrollment. The following data will be collected: At baseline: Socio-demographic information (e.g. age, gender, education level, income, past medical history, social support), health literacy (eligibility screening at time of recruitment), CHD knowledge, medication adherence, and medication self-efficacy. 4-weeks after enrollment: medication self-efficacy and medication adherence.
Investigators
Elaine Siow
Professional Consultant
Chinese University of Hong Kong
Eligibility Criteria
Inclusion Criteria
- •Aged ≥18 years and diagnosed with CHD.
- •Currently receiving pharmacological therapy such as statins, anti-platelet and/or blood thinner, beta-blockers, calcium channel blockers, nitroglycerin, and angiotensin- converting enzyme inhibitors (ACE).
- •Low health literacy score of 9 or less as measured using the short-form Mandarin Health Literacy Scale (s-MHLS).
Exclusion Criteria
- •History of significant cognitive impairment, psychiatric disorders, and aphasia.
- •Without access to a telephone or unable to give telephone contact.
- •Currently enrolled in another program or clinical trial.
Outcomes
Primary Outcomes
Change from baseline medication adherence at 4-weeks follow-up
Time Frame: Baseline and 4-weeks follow-up
Measured using the Chinese version of the Hill-Bone Medication Adherence Scale (HB-MAS). The HB-MAS is a self-reported measure of the extent of medication adherence. The HB-MAS consists of 9 questions with each item rated on a 4-point scale (1 = none of the time; 2 = some of the time; 3 = most of the time; and 4 = all of the time). The total score ranges from 9 (minimum) to 36 (maximum), where lower scores indicate higher levels of medication adherence.
Secondary Outcomes
- Change from baseline medication self-efficacy at 4-weeks follow-up(Baseline and 4-weeks follow-up)